As part of the Technology Development team, James is focused on demonstrating the therapeutic utility of Life Edit’s gene editing systems.
Prior to joining Life Edit, James was a postdoctoral fellow at Fred Hutchinson Cancer Center where he developed high-throughput CRISPR screens to study the function of RNA alternative exons in tumor growth. James earned his PhD in Biomedical Science from the University of Florida where he studied RNA mis-splicing in the disease myotonic dystrophy.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
